In aging mouse hearts, dystroglycan ablation has been demonstrated to produce activity-induced cardiomyopathy by disrupting extracellular matrix interactions, beginning at around 7 months of age (Michele et al., 2009). Here, DAG1 is linked to cardiomyopathy.